In therapeutic areas aimed at developing an orally administered drug, the p
harmacokinetic profile of a drug candidate after oral administration in viv
o is pivotal in evaluating its success. This can be done by monitoring the
plasma concentration versus time after dosing and calculating the area unde
r the curve (AUC). The authors describe a novel screening protocol in which
an estimated AUC can be determined, allowing the rapid evaluation of large
numbers of compounds and providing a rank order of estimated AUC values to
prioritize compounds for further investigation.